Melissa Cruz, Chair of Impact Vitals Board, said,

” As the company continues to evolve, we are committed to regularly evaluating our Board’s composition to ensure we have the right mix of skills and experience to advance our goals. We are thrilled to welcome Andy who will add significant strength to an already talented team.”

Marcus Barkham, CEO and Board Director, said,

“The team is delighted that Andy is joining the Impact Vitals board at this important time. We are confident he will provide valuable perspectives and input as we continue to execute our strategy and enhance value for all Impact Vitals shareholders.”

About Andy Fisher

For the majority of his career Andy held senior positions at United Therapeutics Corporation, a global biotechnology company focused on products that address the needs of patients with chronic and life-threatening conditions. Most recently he was Chief Strategy Officer and Deputy General Counsel. Andy’s expertise is in patent strategy, litigation management, licensing and contract negotiation and development. A lawyer by background, Andy was previously a partner at Mahon Patusky Rothblatt & Fisher.

Andy holds a BA in History from the University of Michigan and a Doctorate of Law from George Washington University Law School.

About

We are a software technology company specializing in artificial intelligence, machine learning and its applications in human physiology.

What we do

We transform sensor-based signals from wearables and medical devices into hydration, heat stress and hemorrhage detection data.

Our Mission & Vision

To provide device agnostic software solutions that unlock meaningful human data and enable actions that improve performance, prevent illness and preserve life.

For inquiries

Please email: info@impactvitals.com